Deutsch | English | Español | Français | Italiano | Português | Русский | العربية | 日本語 | 简体中文 | 繁體中文 | 한국의 | Türk | Polski
LOGO
Global B2B Portal for Bio-Medical & Pharm Industry
Product / Service Supplier Catalogs & Literature    
Search
or
home Product News Catalogs Web TV News & Topics Featured Articles Trade Shows Sourcing Help My allbiomedical
Keyword for News & Topics:
Market News, Trends and Topics
E-mail to Colleague Print
Super-sticky ‘Ultra-bad’ Cholesterol Revealed in People at High Risk of Heart Disease 2011-05-27
Author: Bioscience Technology Staff
From: Bioscience Technology
Scientists from the University of Warwick have discovered why a newly found form of cholesterol seems to be ‘ultra-bad’, leading to increased risk of heart disease. The discovery could lead to new treatments to prevent heart disease particularly in people with type 2 diabetes and the elderly.
Hyperlink to Original Source

Fish Oil May Have Positive Effects on Mood, Alcohol Craving 2011-05-26
Author: Bioscience Technology Staff
From: Bioscience Technology
Omega 3 fatty acids may be beneficial for more than just the heart. Research at the Indiana University School of Medicine disclosed at a molecular level a potential therapeutic benefit between these dietary supplements, alcohol abuse and psychiatric disorders. In a multi-year study, researchers show
Hyperlink to Original Source

P&G Uses 'Omics for Beauty Product Development 2011-05-25
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
Procter & Gamble announced that it will apply its research efforts in the field of 'omics to solve molecular puzzles of beauty and develop innovations in that space. This approach brings together genomics, proteomics, and metabolomics to map the entire biological system, and understand pathways to b
Hyperlink to Original Source

Enzyme Prevents Fatal Heart Condition Associated with Athletes 2011-05-25
Author: University of Manchester
From: Bioscience Technology
Scientists have discovered an important enzyme molecule that may prevent fatal cardiac disorders associated with cardiac hypertrophy – the leading cause of sudden cardiac death in young athletes.
Hyperlink to Original Source

Valeant Pharma in $441M deal for AB Sanitas 2011-05-24
Author: Bioscience Technology Staff
From: Bioscience Technology
Canadian drugmaker Valeant Pharmaceuticals International Inc. said Tuesday it will acquire Lithuanian specialty pharmaceutical company AB Sanitas in a two-stage deal worth 314 million euros ($441.3 million) in cash.
Hyperlink to Original Source

Sutent Approved for Pancreatic Tumors 2011-05-23
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
Pfizer Inc. announced the U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) as the first anti-VEGF therapy to treat progressive pancreatic neuroendocrine tumors (NET) in patients with locally advanced or metastatic disease.
Hyperlink to Original Source

Aspirin, Simvastatin No Help in PAH 2011-05-19
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
Despite their beneficial effects in treating heart disease, neither aspirin nor simvastatin appear to offer benefit to patients suffering from pulmonary artery hypertension (PAH), according to a National Institutes of Health (NIH)-funded study conducted at four U.S. medical centers. This was the fir
Hyperlink to Original Source

FDA Clears First New Hepatitis C Drug in 20 Years 2011-05-16
Author: Matthew Perrone, AP Health Writer
From: Drug Discovery & Development
The Food and Drug Administration approved on May 13 a highly anticipated hepatitis C drug from Merck that is the first new treatment for the virus in 20 years. The first-of-its-kind pill, Victrelis, has been shown to cure more patients in less time than the older drugs now used.
Hyperlink to Original Source

Teva Pharma 1Q profit rises on international sales 2011-05-12
Author: Bioscience Technology Staff
From: Bioscience Technology
The world's largest maker of generic drugs said its profit grew to $761 million, or 84 cents per share, from $714 million, or 79 cents per share, a year ago. Excluding one-time items, Teva said it earned $1.04 per share. Revenue increased 12 percent to $4.08 billion.
Hyperlink to Original Source

FDA grants faster review to Bayer's regorafenib 2011-05-11
Author: Bioscience Technology Staff
From: Bioscience Technology
The Food and Drug Administration will conduct a faster review of Bayer HealthCare Pharmaceuticals Inc.'s cancer drug candidate regorafenib, the company said Tuesday.
Hyperlink to Original Source

Note: The copyright and the ownship of the brand, product names, product numbers, and content mentioned belongs to their repective companies.
e-Newsletter
Update your allbiomedical products information to keep ahead with market trend.
Archive
Subscribe Now!!
View by Categories

Chemical and Material

Contract Manufacturing Services

Cosmetics and Beauty Supplies

Dental Products

Electromedical Diagnostics Equipment

Healthcare Products and Nutritional Supplement

Hospital, Lab and Clean Room Equipment

In-vitro Diagnostics

Manufacturing Equipment

Medical and Surgery Supplies

Medical Imaging

Medical Instrument Components

Medical IT

Medicine, Vaccine and Drug Delivery Systems

Packaging, Labelling, Printing, Barcoding

Pharmaceutical Machinery

Physiotherapy/Orthopaedic Equipment

Services for Medical Industry

Surgery and Endoscopy

Therapy and Physical Medical Devices
My Allbiomedical
Take advantage of the benefits of My %%webname%%
- Track your sourcing projects
- View your search history
- Create a contact list
- Get latest new products and suppliers
- Send inquiries direct to suppliers
- Submit press release, and download detailed suppliers profiles, product profiles, and CAD drawing

Sign-up FREE Now
Featured Articles
Featured Pages
Contents
· Home
· Product News
· Catalogs
· Web TV
· News & Topics
· Features Articles
· Trade Show
· Sourcing Help
· My Allbiomedical
Special Zone
· Directory
· Trade Show Supplement
Allbiomedical.com
· About Us
· Promote Your Business
· Advertise
· Partner with Us
· Press Release
· Contact Us
· Term of Use
· Privacy Policy
· Starter Program
· Sitemap
B2B Web Portal Alliance
· Allitwares.com
· Allmetalworking.com
· Allbiomedical.com
· Allautowares.com
Buy Engineer Sample Kits
OEM Sourcing
Language
· Deutsch
· English
· Español
· Français
· Italiano
· Português
· Русский
· العربية
· 日本語
· 简体中文
· 繁體中文
· 한국의
· Türk
· Polski
 
   

Copyrights © 2012 Allitwares Corporation All Rights Reserved. www.allbiomedical.com is a Division of Allitwares Corporation
www.allbiomedical.com is a B2B Trade Portal | B2B Web Portal |B2B Marketplace for biomedical and pharmaceutical industry